Gastrointestinal (GI) & Pancreatic Cancer Prevention Program
Located at the Digestive Health Center at 8 Devine Street, the Gastrointestinal (GI) & Pancreatic Cancer Prevention Program is an interdisciplinary group of specialists who work together with the goal of providing patients with a personalized cancer risk assessment and taking steps to prevent the development of cancer. It includes the Lynch Syndrome and Polyposis and Hereditary Gastric Cancer Clinics, directed by Xavier Llor, MD, and the Pancreatic Cancer Early Detection Clinic (PCDC), directed by James Farrell, MD.
Our clinical team is committed to providing a comprehensive plan to help assist patients with risk assessment for gastrointestinal cancers, surveillance, surgical decision-making, and follow-up care.
Our Approach
Patients with an identified familial or hereditary cancer risk will receive personalized recommendations for cancer risk management based on their own personal risk assessment. Individuals not suspected of having a genetic predisposition also receive personalized information on how to lower their cancer risk. These interventions can have a huge impact on a person’s life by allowing them to better manage their health and reduce their risk of ever developing cancer.